AMT medical is a clinical stage medical device company based in the Netherlands. The ELANA solution is based on a proven similar solution for the brain. This ELANA brain solution was introduced to the market by ELANA B.V., a company earlier founded by the CEO and the team of AMT medical.
The St. Antonius Hospital in Nieuwegein, the Netherlands, and Charité / The German Heart Center in Berlin, Germany, are the first expert centers to bring the procedure into clinical practice. AMT medical firmly believes “Together we are better“, hence they work daily with clinical specialists, advisors, and our investors. The AMT medical team is vital to reach our goals; a diverse team of junior and senior members, with an extensive track record in R&D innovations, quality, regulatory, and bringing clinical solutions to patients.
The St. Antonius Hospital in Nieuwegein, the Netherlands, and Charité / The German Heart Center in Berlin, Germany, are the first expert centers to bring the procedure into clinical practice. AMT medical firmly believes “Together we are better“, hence they work daily with clinical specialists, advisors, and our investors. The AMT medical team is vital to reach our goals; a diverse team of junior and senior members, with an extensive track record in R&D innovations, quality, regulatory, and bringing clinical solutions to patients.
Location: Netherlands, Gelderland, Ede
Employees: 11-50
Total raised: $25M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Utrecht Ho... | utrechthol... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.04.2025 | Series B | $25M | - |
Mentions in press and media 7
| Date | Title | Description |
| 19.04.2025 | AMT Medical Secures $25 Million to Revolutionize Heart Surgery | In a bold move to reshape the landscape of cardiac surgery, AMT Medical has successfully raised $25 million in a Series B funding round. This clinical-stage medtech company, based in the Netherlands, is on a mission to transform coronary ar... |
| 18.04.2025 | AMT Medical: $25 Million (Series B) Closed To Transform Coronary Artery Bypass Surgery | AMT Medical, a clinical-stage medtech innovator, announced a $25 million Series B financing round led by Bender Analytical Holding B.V. (BAH). New investors Invest-NL and the European Innovation Council (EIC) joined existing backers Oost NL... |
| 17.04.2025 | AMT Medical Raises $25M in Series B Funding | AMT Medical, an Ede and Utrecht, the Netherlands-based clinical-stage medtech company, raised $25M in Series B funding. The round was led by Bender Analytical Holding B.V. (BAH). Other investors Invest-NL, and the European Innovation Counci... |
| 30.12.2022 | Dutch-based biotech and life sciences startups that raised funding in 2022 | The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. More and more Dutch startups are engaged in a range of cutting-edge initiatives, such as the creation of digital health tools, the developmen... |
| 08.10.2022 | ELANA® Heart Bypass Solution shows promising preliminary results in first-in-human trials | Results now available for the first 10 patients being treated with the ELANA open heart bypass solution as part of a SAFE-CAB trial. ELANA Heart Bypass Solution shown to be safe and feasible in humans, with all candidates free of Major Adve... |
| 12.07.2022 | EIC Accelerator: EIC announces major funding to 74 European startups; 5 are from the Netherlands | The European Commission (EC) announced on June 7 that it has selected 74 innovative companies under the first 2022 EIC Accelerator cut-off. The companies announced were among 1093 applicants who submitted to the first 2022 cut-off dated Mar... |
| - | AMT Medical | “AMT Medical – The future of bypass surgery” |